Table 3 Intra- and inter-group comparison of insulin resistance indices in subjects before and after intervention in LIPC and Sham groups

TyG

 Baseline

9.04 ± 0.57

8.82 ± 0.59

0.148

 Endpoint

8.54 ± 0.58

8.76 ± 0.51

0.123

 Change^c

-0.50 ± 0.40

-0.07 ± 0.39

<0.001

Pvalue^d(within)

<0.001

0.356

<0.001^e

TyG-BMI

 Baseline

198.66(182.08,230.62)

198.49(171.16,226.24)

0.632

 Endpoint

188.92(161.15,214.02)

195.25(174.62,225.51)

0.284

 Change

-16.52(-21.78,-5.71)

5.30(-6.52,9.47)

<0.001

P value(within)

<0.001

0.443

<0.001

TG/HDL

 Baseline

4.04(2.87,5.65)

2.98(1.90,4.58)

0.081

 Endpoint

3.30(2.00,4.81)

3.29(1.97,5.20)

0.554

 Change

-0.58(-1.69,-0.06)

0.38(-0.24,1.18)

<0.001

P value(within)

0.007

0.112

0.018

METS-IR

 Baseline

36.25(33.09,41.33)

35.98(30.34,42.57)

0.545

 Endpoint

33.61(30.14,40.43)

35.34(32.97,41.22)

0.345

 Change

-1.32(-3.90,0.84)

0.65(-1.51,2.78)

0.03

P value(within)

0.03

0.369

0.032